"Consolidated Balance Sheet as at 31 December 2018 2017 2018 Restated Note m m Non-current assets Property, plant and equipment 10 105.4 118.1 Goodwill 12 293.9 312.2 Intangible assets 13 46.2 57.0 Deferred tax assets 23 14.6 13.7 Derivative financial instruments 19 1.9 0.1 Deferred consideration 19 0.7 1.4 462.7 502.5 Current assets Inventories 15 207.2 243.5 Trade and other receivables 16 477.7 480.4 Contract assets 16 1.8 Current tax assets 16 5.5 5.2 Derivative financial instruments 19 1.2 Deferred consideration 19 0.8 0.1 Cash at bank and on hand 19 83.3 108.2 Assets classified as held for sale 10 1.9 0.3 778.2 838.9 Total assets 1,240.9 1,341.4 Current liabilities Trade and other payables 17 428.3 421.5 Contract liabilities 17 1.6 Obligations under finance lease contracts 17 3.2 3.2 Bank overdrafts 17 4.5 29.6 Bank loans 17 56.5 84.2 Private placement notes 17 21.1 Loan notes and deferred consideration 17 0.9 17.0 Other financial liabilities 17 1.1 8.0 Derivative financial instruments 17 0.3 0.2 Current tax liabilities 17 4.9 7.2 Provisions 17 11.0 12.0 Liabilities directly associated with assets classified as held for sale 17 0.1 512.3 604.1 Non-current liabilities Obligations under finance lease contracts 18 20.2 20.0 Bank loans 18 Private placement notes 18 185.6 183.1 Derivative financial instruments 18 3.8 3.3 Deferred tax liabilities 23 1.4 1.4 Other payables 18 5.6 6.9 Retirement benefit obligations 29c 28.7 30.4 Provisions 18 20.4 21.7 265.7 266.8 Total liabilities 778.0 870.9 Net assets 462.9 470.5 Capital and reserves Called up share capital 25 59.2 59.2 Share premium account 447.3 447.3 Capital redemption reserve 0.3 0.3 Share option reserve 1.7 1.3 Hedging and translation reserve 21.7 19.6 Cost of hedging reserve 1.0 Retained losses 68.3 58.1 Attributable to equity holders of the Company 462.9 469.6 Non-controlling interests 0.9 Total equity 462.9 470.5 The Group has initially applied IFRS 15 ""Revenue from contracts with customers"" using the modified retrospective method."
Under this method, the comparative information is not restated.
"The Group has applied IFRS 9 ""Financial instruments"" retrospectively but without restating comparative information."
See the Statement of Significant Accounting Policies for further details.
The 2017 Consolidated Balance Sheet has been restated as set out in the Statement of Significant Accounting Policies and Note 33.
The accompanying Statement of Significant Accounting Policies and Notes to the Financial Statements are an integral part of this Consolidated Balance Sheet.
The Financial Statements were approved by the Board of Directors on 7 March 2019 and signed on its behalf by: MEINIE OLDERSMA NICK MADDOCK Director Director Registered in England: 00998314 110 SIG plc Annual Report and Accounts for the year ended 31 December 2018 FINANCIALS
